Computational Modeling of T Cell Receptor Complexes.

T-cell receptor (TCR) binding to peptide/MHC determines specificity and initiates signaling in antigen-specific cellular immune responses. Structures of TCR-pMHC complexes have provided enormous insight to cellular immune functions, permitted a rational understanding of processes such as pathogen escape, and led to the development of novel approaches for the design of vaccines and other therapeutics. As production, crystallization, and structure determination of TCR-pMHC complexes can be challenging, there is considerable interest in modeling new complexes. Here we describe a rapid approach to TCR-pMHC modeling that takes advantage of structural features conserved in known complexes, such as the restricted TCR binding site and the generally conserved diagonal docking mode. The approach relies on the powerful Rosetta suite and is implemented using the PyRosetta scripting environment. We show how the approach can recapitulate changes in TCR binding angles and other structural details, and highlight areas where careful evaluation of parameters is needed and alternative choices might be made. As TCRs are highly sensitive to subtle structural perturbations, there is room for improvement. Our method nonetheless generates high-quality models that can be foundational for structure-based hypotheses regarding TCR recognition.

[1]  Robyn L. Stanfield,et al.  An αβ T Cell Receptor Structure at 2.5 Å and Its Orientation in the TCR-MHC Complex , 1996, Science.

[2]  U. Utz,et al.  Analysis of the T-cell receptor repertoire of human T-cell leukemia virus type 1 (HTLV-1) Tax-specific CD8+ cytotoxic T lymphocytes from patients with HTLV-1-associated disease: evidence for oligoclonal expansion , 1996, Journal of virology.

[3]  Partho Ghosh,et al.  Structure of the complex between human T-cell receptor, viral peptide and HLA-A2 , 1996, Nature.

[4]  R Elber,et al.  Knowledge-based structure prediction of MHC class I bound peptides: a study of 23 complexes. , 1998, Folding & design.

[5]  Z Reich,et al.  Ligand recognition by alpha beta T cell receptors. , 1998, Annual review of immunology.

[6]  B M Baker,et al.  Four A6-TCR/peptide/HLA-A2 structures that generate very different T cell signals are nearly identical. , 1999, Immunity.

[7]  Partho Ghosh,et al.  The Structure and Stability of an HLA-A*0201/Octameric Tax Peptide Complex with an Empty Conserved Peptide-N-Terminal Binding Site1 , 2000, The Journal of Immunology.

[8]  M Karplus,et al.  Modeling of the TCR-MHC-peptide complex. , 2000, Journal of molecular biology.

[9]  Jeffrey J. Gray,et al.  Protein-protein docking with simultaneous optimization of rigid-body displacement and side-chain conformations. , 2003, Journal of molecular biology.

[10]  Andrew Sewell,et al.  Structural and kinetic basis for heightened immunogenicity of T cell vaccines , 2005, The Journal of experimental medicine.

[11]  Robyn L Stanfield,et al.  How TCRs bind MHCs, peptides, and coreceptors. , 2006, Annual review of immunology.

[12]  O. Michielin,et al.  Structural prediction of peptides bound to MHC class I. , 2006, Journal of molecular biology.

[13]  Brian M Baker,et al.  T cell receptor recognition via cooperative conformational plasticity. , 2006, Journal of molecular biology.

[14]  S. Rosenberg,et al.  Gene Transfer of Tumor-Reactive TCR Confers Both High Avidity and Tumor Reactivity to Nonreactive Peripheral Blood Mononuclear Cells and Tumor-Infiltrating Lymphocytes1 , 2006, The Journal of Immunology.

[15]  Andrew K. Sewell,et al.  Human TCR-Binding Affinity is Governed by MHC Class Restriction1 , 2007, The Journal of Immunology.

[16]  Brian M Baker,et al.  Structures of MART-126/27-35 Peptide/HLA-A2 complexes reveal a remarkable disconnect between antigen structural homology and T cell recognition. , 2007, Journal of molecular biology.

[17]  Jeffrey J. Gray,et al.  Conformer selection and induced fit in flexible backbone protein-protein docking using computational and NMR ensembles. , 2008, Journal of molecular biology.

[18]  K. M. Armstrong,et al.  Fluorine substitutions in an antigenic peptide selectively modulate T-cell receptor binding in a minimally perturbing manner. , 2009, The Biochemical journal.

[19]  James McCluskey,et al.  T cell allorecognition via molecular mimicry. , 2009, Immunity.

[20]  E. Coutsias,et al.  Sub-angstrom accuracy in protein loop reconstruction by robotics-inspired conformational sampling , 2009, Nature Methods.

[21]  Kurt H Piepenbrink,et al.  T cell receptor cross-reactivity directed by antigen-dependent tuning of peptide-MHC molecular flexibility. , 2009, Immunity.

[22]  S. Sainsbury,et al.  Some lessons from the systematic production and structural analysis of soluble (alpha)(beta) T-cell receptors. , 2009, Journal of immunological methods.

[23]  G. Gao,et al.  Germ Line-governed Recognition of a Cancer Epitope by an Immunodominant Human T-cell Receptor* , 2009, The Journal of Biological Chemistry.

[24]  James Robinson,et al.  The IMGT/HLA database , 2008, Nucleic Acids Res..

[25]  Gabriele Di Sante,et al.  Modeling the Ternary Complex TCR-Vβ/CollagenII(261–273)/HLA-DR4 Associated with Rheumatoid Arthritis , 2010, PloS one.

[26]  Sergey Lyskov,et al.  PyRosetta: a script-based interface for implementing molecular modeling algorithms using Rosetta , 2010, Bioinform..

[27]  Samuel L. DeLuca,et al.  Practically Useful: What the Rosetta Protein Modeling Suite Can Do for You , 2010, Biochemistry.

[28]  B. Baker,et al.  Disparate degrees of hypervariable loop flexibility control T-cell receptor cross-reactivity, specificity, and binding mechanism. , 2011, Journal of molecular biology.

[29]  K. Garcia,et al.  T cell receptor signaling is limited by docking geometry to peptide-major histocompatibility complex. , 2011, Immunity.

[30]  B. Baker,et al.  Conformational Melding Permits a Conserved Binding Geometry in TCR Recognition of Foreign and Self Molecular Mimics , 2011, The Journal of Immunology.

[31]  Chen Yanover,et al.  Large-scale characterization of peptide-MHC binding landscapes with structural simulations , 2011, Proceedings of the National Academy of Sciences.

[32]  Olivier Michielin,et al.  TCRep 3D: An Automated In Silico Approach to Study the Structural Properties of TCR Repertoires , 2011, PloS one.

[33]  B. Baker,et al.  TCRs Used in Cancer Gene Therapy Cross-React with MART-1/Melan-A Tumor Antigens via Distinct Mechanisms , 2011, The Journal of Immunology.

[34]  A. Sewell,et al.  TCR/pMHC Optimized Protein crystallization Screen , 2012, Journal of immunological methods.

[35]  J. Drijfhout,et al.  Structural basis of human β-cell killing by CD8+ T cells in Type 1 diabetes , 2011, Nature Immunology.

[36]  Steven A. Rosenberg,et al.  Adoptive immunotherapy for cancer: harnessing the T cell response , 2012, Nature Reviews Immunology.

[37]  B. Jakobsen,et al.  ImmTACs: Novel bi-specific agents for targeted cancer therapy. , 2013, Oncoimmunology.

[38]  Min-Sun Park,et al.  Accurate structure prediction of peptide-MHC complexes for identifying highly immunogenic antigens. , 2013, Molecular immunology.

[39]  Yu-Shu Lo,et al.  Genome-wide structural modelling of TCR-pMHC interactions , 2013, BMC Genomics.

[40]  Z. Weng,et al.  A flexible docking approach for prediction of T cell receptor–peptide–MHC complexes , 2013, Protein science : a publication of the Protein Society.

[41]  Zhiping Weng,et al.  Modeling T cell receptor recognition of CD1-lipid and MR1-metabolite complexes , 2014, BMC Bioinformatics.

[42]  B. Walker,et al.  The complex and specific pMHC interactions with diverse HIV-1 TCR clonotypes reveal a structural basis for alterations in CTL function , 2014, Scientific Reports.

[43]  J. McCluskey,et al.  Understanding the complexity and malleability of T‐cell recognition , 2015, Immunology and cell biology.

[44]  Michael Schantz Klausen,et al.  LYRA, a webserver for lymphocyte receptor structural modeling , 2015, Nucleic Acids Res..